| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone kinase activity | 7.94e-06 | 28 | 92 | 4 | GO:0035173 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.08e-05 | 229 | 92 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 2.08e-04 | 5 | 92 | 2 | GO:0141003 | |
| GeneOntologyBiologicalProcess | myoblast fate commitment | 2.87e-06 | 7 | 91 | 3 | GO:0048625 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.39e-05 | 178 | 91 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | myoblast fate determination | 1.93e-05 | 2 | 91 | 2 | GO:0007518 | |
| GeneOntologyBiologicalProcess | regulation of DNA replication | 4.79e-05 | 147 | 91 | 6 | GO:0006275 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication | 7.56e-05 | 51 | 91 | 4 | GO:0044786 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | KLF11 SETD2 DIS3L2 ATR ATAD5 RBBP8 MKI67 BAZ1B RAD9B SENP2 CCNY PCNT PHF13 | 9.27e-05 | 854 | 91 | 13 | GO:1903047 |
| GeneOntologyBiologicalProcess | regulation of DNA endoreduplication | 1.15e-04 | 4 | 91 | 2 | GO:0032875 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA replication | 1.25e-04 | 58 | 91 | 4 | GO:0045740 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | KLF11 SETD2 DIS3L2 ATR ATAD5 RBBP8 MKI67 BAZ1B RAD9B SENP2 E2F8 CCNY PCNT PHF13 | 1.37e-04 | 1014 | 91 | 14 | GO:0000278 |
| GeneOntologyBiologicalProcess | cell cycle process | KLF11 SETD2 MYH9 DIS3L2 ATR ATRX ATAD5 RBBP8 MKI67 BAZ1B RAD9B SENP2 PLCG2 E2F8 CCNY PCNT PHF13 | 1.67e-04 | 1441 | 91 | 17 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA endoreduplication | 1.91e-04 | 5 | 91 | 2 | GO:0042023 | |
| GeneOntologyCellularComponent | myosin II filament | 5.36e-05 | 3 | 89 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 3.38e-04 | 32 | 89 | 3 | GO:0005721 | |
| HumanPheno | Narrow face | 3.10e-05 | 108 | 30 | 6 | HP:0000275 | |
| HumanPheno | Bowel urgency | 3.35e-05 | 2 | 30 | 2 | HP:0012701 | |
| Domain | ZF_PHD_2 | 7.40e-06 | 95 | 92 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 7.87e-06 | 96 | 92 | 6 | PS01359 | |
| Domain | Znf_FYVE_PHD | 8.12e-06 | 147 | 92 | 7 | IPR011011 | |
| Domain | WAC_Acf1_DNA_bd | 2.40e-05 | 2 | 92 | 2 | PF10537 | |
| Domain | WAC | 2.40e-05 | 2 | 92 | 2 | PS51136 | |
| Domain | WSTF_Acf1_Cbp146 | 2.40e-05 | 2 | 92 | 2 | IPR013136 | |
| Domain | PHD | 3.42e-05 | 75 | 92 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 4.39e-05 | 79 | 92 | 5 | IPR019787 | |
| Domain | BAT2_N | 7.18e-05 | 3 | 92 | 2 | PF07001 | |
| Domain | BAT2_N | 7.18e-05 | 3 | 92 | 2 | IPR009738 | |
| Domain | PRRC2 | 7.18e-05 | 3 | 92 | 2 | IPR033184 | |
| Domain | PHD | 7.78e-05 | 89 | 92 | 5 | SM00249 | |
| Domain | Znf_PHD | 8.65e-05 | 91 | 92 | 5 | IPR001965 | |
| Domain | Ank_2 | 9.30e-05 | 215 | 92 | 7 | PF12796 | |
| Domain | Ank | 1.34e-04 | 228 | 92 | 7 | PF00023 | |
| Domain | - | 2.24e-04 | 248 | 92 | 7 | 1.25.40.20 | |
| Domain | DDT | 2.38e-04 | 5 | 92 | 2 | SM00571 | |
| Domain | WSD | 2.38e-04 | 5 | 92 | 2 | PF15613 | |
| Domain | WHIM1 | 2.38e-04 | 5 | 92 | 2 | PF15612 | |
| Domain | DDT_dom | 2.38e-04 | 5 | 92 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 2.38e-04 | 5 | 92 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 2.38e-04 | 5 | 92 | 2 | IPR028941 | |
| Domain | ANK | 2.42e-04 | 251 | 92 | 7 | SM00248 | |
| Domain | HR1_rho-bd | 2.46e-04 | 25 | 92 | 3 | IPR011072 | |
| Domain | ANK_REPEAT | 2.54e-04 | 253 | 92 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.60e-04 | 254 | 92 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.60e-04 | 254 | 92 | 7 | PS50297 | |
| Domain | Zinc_finger_PHD-type_CS | 2.97e-04 | 65 | 92 | 4 | IPR019786 | |
| Domain | Ankyrin_rpt | 3.13e-04 | 262 | 92 | 7 | IPR002110 | |
| Domain | DDT | 3.55e-04 | 6 | 92 | 2 | PS50827 | |
| Domain | BROMODOMAIN_1 | 7.96e-04 | 37 | 92 | 3 | PS00633 | |
| Domain | BROMODOMAIN_2 | 1.08e-03 | 41 | 92 | 3 | PS50014 | |
| Domain | BROMO | 1.16e-03 | 42 | 92 | 3 | SM00297 | |
| Domain | Bromodomain | 1.16e-03 | 42 | 92 | 3 | IPR001487 | |
| Domain | - | 1.16e-03 | 42 | 92 | 3 | 1.20.920.10 | |
| Domain | SH3_1 | 1.31e-03 | 164 | 92 | 5 | PF00018 | |
| Domain | Roc | 1.81e-03 | 13 | 92 | 2 | PF08477 | |
| Domain | MIRO-like | 1.81e-03 | 13 | 92 | 2 | IPR013684 | |
| Domain | Myosin_N | 2.42e-03 | 15 | 92 | 2 | PF02736 | |
| Domain | Myosin_N | 2.42e-03 | 15 | 92 | 2 | IPR004009 | |
| Domain | PH | 2.52e-03 | 278 | 92 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 2.57e-03 | 279 | 92 | 6 | PS50003 | |
| Domain | PH_domain | 2.61e-03 | 280 | 92 | 6 | IPR001849 | |
| Domain | BHLH | 2.67e-03 | 117 | 92 | 4 | PS50888 | |
| Domain | bZIP_2 | 3.11e-03 | 17 | 92 | 2 | PF07716 | |
| Domain | Myosin_tail_1 | 3.49e-03 | 18 | 92 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.49e-03 | 18 | 92 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 3.89e-03 | 19 | 92 | 2 | IPR027401 | |
| Domain | - | 3.89e-03 | 19 | 92 | 2 | 4.10.270.10 | |
| Domain | SH3 | 4.30e-03 | 216 | 92 | 5 | SM00326 | |
| Domain | SH3 | 4.30e-03 | 216 | 92 | 5 | PS50002 | |
| Domain | SH3_domain | 4.65e-03 | 220 | 92 | 5 | IPR001452 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FNBP1 KDM3A SETD2 PPIG ATR ATRX KDM5A DSP RBBP8 MKI67 TATDN2 BAZ1B ANXA9 PRRC2A CCNY MPG | 3.34e-10 | 774 | 95 | 16 | 15302935 |
| Pubmed | PRPF31 SETD2 IFRD1 ATRX KDM5A BAZ1A ATAD5 ATP13A1 ARHGAP10 INTS11 ANKRD11 BAZ1B SRP68 TANC1 SRBD1 PRRC2A AGAP1 MPRIP AGAP3 MPG | 3.29e-09 | 1497 | 95 | 20 | 31527615 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRPF31 SETD2 PPIG MYH9 ATR ATRX KDM5A DSP BAZ1A ATAD5 NFIL3 INTS11 MKI67 ANKRD11 BAZ1B SRBD1 SP110 MPG | 1.22e-08 | 1294 | 95 | 18 | 30804502 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP350 CCDC88C PRPF31 IFRD1 KDM5A DSP DSTYK ANKRD11 TANC1 TSSK1B LYST DNAH7 E2F8 MPRIP AGAP3 | 1.25e-08 | 861 | 95 | 15 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MST1 SETD2 ATRX DSP RBBP8 NCF1 BAZ1B TANC1 PRRC2B MPRIP PCNT | 6.37e-07 | 588 | 95 | 11 | 38580884 |
| Pubmed | 8.25e-07 | 116 | 95 | 6 | 21282530 | ||
| Pubmed | Convergence and extrusion are required for normal fusion of the mammalian secondary palate. | 1.09e-06 | 8 | 95 | 3 | 25848986 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.09e-06 | 8 | 95 | 3 | 12634303 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.44e-06 | 202 | 95 | 7 | 33005030 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SETD2 MYH9 ATRX DSP BAZ1A ATAD5 MKI67 BAZ1B SRP68 PRRC2A PRRC2B MPRIP PCNT | 1.59e-06 | 934 | 95 | 13 | 33916271 |
| Pubmed | 2.03e-06 | 75 | 95 | 5 | 25593309 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 2.88e-06 | 36 | 95 | 4 | 25615642 | |
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 3.21e-06 | 11 | 95 | 3 | 33347679 | |
| Pubmed | 3.75e-06 | 332 | 95 | 8 | 37433992 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 MYH9 DIS3L2 DSP MYH14 BAZ1A INTS11 MKI67 BAZ1B SRP68 TANC1 PLCG2 SRBD1 MPRIP MPG | 3.89e-06 | 1353 | 95 | 15 | 29467282 |
| Pubmed | Intrinsic neural stem cell properties define brain hypersensitivity to genotoxic stress. | 4.27e-06 | 12 | 95 | 3 | 35623353 | |
| Pubmed | 4.46e-06 | 340 | 95 | 8 | 24332808 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CEP350 PRPF31 KDM5A MYH14 ATAD5 PRKAA1 MKI67 SRP68 PRRC2A PRRC2B MPRIP | 4.72e-06 | 724 | 95 | 11 | 36232890 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.60e-06 | 608 | 95 | 10 | 36089195 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21127072 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17512409 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21998596 | ||
| Pubmed | Frequency and amplitude control of cortical oscillations by phosphoinositide waves. | 7.38e-06 | 2 | 95 | 2 | 26751515 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34374341 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34074749 | ||
| Pubmed | Activation of DSB processing requires phosphorylation of CtIP by ATR. | 7.38e-06 | 2 | 95 | 2 | 23273981 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26851078 | ||
| Pubmed | 9.53e-06 | 177 | 95 | 6 | 26206133 | ||
| Pubmed | 1.08e-05 | 16 | 95 | 3 | 22438570 | ||
| Pubmed | 1.11e-05 | 106 | 95 | 5 | 19394292 | ||
| Pubmed | 1.30e-05 | 187 | 95 | 6 | 26460568 | ||
| Pubmed | CEP350 PPIG MYH9 KDM5A DSP MYH14 BAZ1A ATP13A1 INTS11 MKI67 SRP68 PRRC2A PRRC2B MPRIP | 2.12e-05 | 1371 | 95 | 14 | 36244648 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 14502124 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20685736 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22452996 | ||
| Pubmed | SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways. | 2.21e-05 | 3 | 95 | 2 | 32619406 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 15177565 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 12705871 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 15774463 | ||
| Pubmed | AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy. | 2.21e-05 | 3 | 95 | 2 | 32098961 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 32554528 | ||
| Pubmed | Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection. | 2.21e-05 | 3 | 95 | 2 | 28637903 | |
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 2.21e-05 | 3 | 95 | 2 | 14594953 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16326391 | ||
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 2.21e-05 | 3 | 95 | 2 | 24072716 | |
| Pubmed | Non-canonical reader modules of BAZ1A promote recovery from DNA damage. | 2.21e-05 | 3 | 95 | 2 | 29021563 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 15845534 | ||
| Pubmed | 2.53e-05 | 21 | 95 | 3 | 26468281 | ||
| Pubmed | Programmed cell senescence during mammalian embryonic development. | 2.53e-05 | 21 | 95 | 3 | 24238962 | |
| Pubmed | 2.53e-05 | 21 | 95 | 3 | 23034633 | ||
| Pubmed | 2.93e-05 | 22 | 95 | 3 | 38507412 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MST1 ADAMTS19 MYH9 MYH14 IRAG2 BAZ1B CD300LG CC2D1B ANXA9 GALNT18 PRRC2B AGAP1 MPG | 3.33e-05 | 1242 | 95 | 13 | 30973865 |
| Pubmed | A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy. | 3.36e-05 | 23 | 95 | 3 | 28162974 | |
| Pubmed | Mycn deficiency underlies the development of orofacial clefts in mice and humans. | 3.83e-05 | 24 | 95 | 3 | 34590686 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.27e-05 | 231 | 95 | 6 | 16452087 | |
| Pubmed | SENP2 Suppresses Necdin Expression to Promote Brown Adipocyte Differentiation. | 4.35e-05 | 25 | 95 | 3 | 31433978 | |
| Pubmed | Mst1 directs Myosin IIa partitioning of low and higher affinity integrins during T cell migration. | 4.41e-05 | 4 | 95 | 2 | 25133611 | |
| Pubmed | AKAP350 interaction with cdc42 interacting protein 4 at the Golgi apparatus. | 4.41e-05 | 4 | 95 | 2 | 15047863 | |
| Pubmed | A requirement of Polo-like kinase 1 in murine embryonic myogenesis and adult muscle regeneration. | 4.41e-05 | 4 | 95 | 2 | 31393265 | |
| Pubmed | Involvement of vessels and PDGFB in muscle splitting during chick limb development. | 4.41e-05 | 4 | 95 | 2 | 17553906 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17600711 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 15743821 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 33877886 | ||
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 4.41e-05 | 4 | 95 | 2 | 18697221 | |
| Pubmed | Embryonic expression of pericentrin suggests universal roles in ciliogenesis. | 4.41e-05 | 4 | 95 | 2 | 16534625 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16630611 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 26334330 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17593084 | ||
| Pubmed | An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation. | 4.41e-05 | 4 | 95 | 2 | 22370720 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 30061681 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 14506264 | ||
| Pubmed | CEP350 KDM3A ATRX ADAMTS9 KDM5A DSP MYH14 ATP13A1 PRRC2A AGAP1 MPRIP PCNT AGAP3 | 4.72e-05 | 1285 | 95 | 13 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CCDC88C ATP13A1 INTS11 ANKRD11 SENP2 TANC1 LYST PRRC2B NBPF1 MPRIP PCNT AGAP3 | 4.82e-05 | 1105 | 95 | 12 | 35748872 |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 4.90e-05 | 26 | 95 | 3 | 30923192 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PRPF31 SETD2 IFRD1 ATRX DSP BAZ1A ATAD5 MKI67 ANKRD11 BAZ1B PRRC2A | 5.98e-05 | 954 | 95 | 11 | 36373674 |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 6.16e-05 | 28 | 95 | 3 | 24462114 | |
| Pubmed | 6.37e-05 | 493 | 95 | 8 | 15368895 | ||
| Pubmed | 6.76e-05 | 251 | 95 | 6 | 31076518 | ||
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 7.34e-05 | 5 | 95 | 2 | 19439495 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 15804569 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 33871354 | ||
| Pubmed | Cloning and characterization of a novel MyoD enhancer-binding factor. | 7.34e-05 | 5 | 95 | 2 | 17693064 | |
| Pubmed | Morphogenesis and Compartmentalization of the Intestinal Crypt. | 7.34e-05 | 5 | 95 | 2 | 29689194 | |
| Pubmed | Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly. | 7.34e-05 | 5 | 95 | 2 | 23892236 | |
| Pubmed | Expression analysis of limb element markers during mouse embryonic development. | 7.34e-05 | 5 | 95 | 2 | 30225906 | |
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 7.34e-05 | 5 | 95 | 2 | 25006807 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 29183906 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 10662543 | ||
| Pubmed | Relationship between neural crest cells and cranial mesoderm during head muscle development. | 7.34e-05 | 5 | 95 | 2 | 19198652 | |
| Pubmed | 7.34e-05 | 157 | 95 | 5 | 30186101 | ||
| Pubmed | 7.41e-05 | 650 | 95 | 9 | 38777146 | ||
| Pubmed | 7.68e-05 | 653 | 95 | 9 | 22586326 | ||
| Pubmed | FAM50B PRPF31 SETD2 PPIG MYH9 ATR ATRX BAZ1A ATAD5 MKI67 BAZ1B | 1.03e-04 | 1014 | 95 | 11 | 32416067 | |
| Pubmed | 1.05e-04 | 272 | 95 | 6 | 31010829 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.07e-04 | 394 | 95 | 7 | 27248496 | |
| Pubmed | PRPF31 MYH9 MYH14 BAZ1A MKI67 BAZ1B SRP68 TRIP10 PRRC2A MPRIP | 1.09e-04 | 847 | 95 | 10 | 35850772 | |
| Pubmed | Nonmuscle myosin II regulation of lung epithelial morphology. | 1.10e-04 | 6 | 95 | 2 | 22972683 | |
| Pubmed | Directionality of developing skeletal muscles is set by mechanical forces. | 1.10e-04 | 6 | 95 | 2 | 37244931 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 15034141 | ||
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 17118963 | ||
| Interaction | LRRC31 interactions | 5.70e-06 | 205 | 95 | 8 | int:LRRC31 | |
| Interaction | DUXA interactions | 2.16e-05 | 12 | 95 | 3 | int:DUXA | |
| Interaction | PNMA2 interactions | 2.47e-05 | 251 | 95 | 8 | int:PNMA2 | |
| Interaction | CXCL6 interactions | 2.72e-05 | 37 | 95 | 4 | int:CXCL6 | |
| Cytoband | 2q24.2 | 9.53e-04 | 22 | 95 | 2 | 2q24.2 | |
| Cytoband | 9p12 | 1.66e-03 | 29 | 95 | 2 | 9p12 | |
| GeneFamily | PHD finger proteins | 1.53e-05 | 90 | 63 | 5 | 88 | |
| GeneFamily | Ankyrin repeat domain containing | 2.06e-05 | 242 | 63 | 7 | 403 | |
| GeneFamily | Myosin heavy chains | 1.22e-03 | 15 | 63 | 2 | 1098 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.57e-03 | 17 | 63 | 2 | 1291 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.97e-03 | 19 | 63 | 2 | 50 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 2.18e-03 | 20 | 63 | 2 | 433 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 2.88e-03 | 23 | 63 | 2 | 1288 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.14e-03 | 24 | 63 | 2 | 485 | |
| GeneFamily | ArfGAPs | 5.89e-03 | 33 | 63 | 2 | 395 | |
| GeneFamily | Basic helix-loop-helix proteins | 6.68e-03 | 110 | 63 | 3 | 420 | |
| Coexpression | BENPORATH_PRC2_TARGETS | ANKRD20A5P MYOD1 STK32B SLIT1 RPS6KA6 ANKRD20A2P GRIK3 ANKRD20A3P ANKRD20A8P GALNT18 EPAS1 ANKRD20A1 | 4.09e-06 | 650 | 95 | 12 | M8448 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.94e-05 | 90 | 95 | 5 | M39250 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CEP350 CCDC88C FNBP1 SETD2 PPIG MYH9 ATR ATRX KDM5A BAZ1A DSTYK ANKRD11 BAZ1B PARP14 SP110 LYST PRRC2B | 2.36e-05 | 1492 | 95 | 17 | M40023 |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 9.08e-09 | 196 | 94 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-07 | 178 | 94 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-07 | 191 | 94 | 7 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-07 | 191 | 94 | 7 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.28e-07 | 200 | 94 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.28e-07 | 200 | 94 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 8.58e-07 | 152 | 94 | 6 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-06 | 173 | 94 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 177 | 94 | 6 | b41e975e8368e2618b015be095efe8c0e001c78b | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 177 | 94 | 6 | 15d1de38e4f1a0d4a786d83ee92240f44bdff006 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 182 | 94 | 6 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.52e-06 | 183 | 94 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 184 | 94 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.69e-06 | 185 | 94 | 6 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 2.86e-06 | 187 | 94 | 6 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.64e-06 | 195 | 94 | 6 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.64e-06 | 195 | 94 | 6 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.64e-06 | 195 | 94 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 3.64e-06 | 195 | 94 | 6 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.86e-06 | 197 | 94 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 94 | 6 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.20e-05 | 159 | 94 | 5 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-05 | 164 | 94 | 5 | 6a113191ea91d103d21c5f056b1950217688ea26 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.71e-05 | 166 | 94 | 5 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-05 | 175 | 94 | 5 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 181 | 94 | 5 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 181 | 94 | 5 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 181 | 94 | 5 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-05 | 185 | 94 | 5 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 187 | 94 | 5 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.78e-05 | 187 | 94 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 187 | 94 | 5 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-05 | 188 | 94 | 5 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 5.03e-05 | 189 | 94 | 5 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.16e-05 | 190 | 94 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 5.16e-05 | 190 | 94 | 5 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 190 | 94 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 94 | 5 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.29e-05 | 191 | 94 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 191 | 94 | 5 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 94 | 5 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.42e-05 | 192 | 94 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-05 | 192 | 94 | 5 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.42e-05 | 192 | 94 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 5.42e-05 | 192 | 94 | 5 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.42e-05 | 192 | 94 | 5 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 5.56e-05 | 193 | 94 | 5 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.56e-05 | 193 | 94 | 5 | 024d30eb143d8278c0851c3a6c9426226fa3b480 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.56e-05 | 193 | 94 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.69e-05 | 194 | 94 | 5 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.69e-05 | 194 | 94 | 5 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-05 | 194 | 94 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 194 | 94 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.69e-05 | 194 | 94 | 5 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-05 | 195 | 94 | 5 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.83e-05 | 195 | 94 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-05 | 196 | 94 | 5 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.98e-05 | 196 | 94 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.98e-05 | 196 | 94 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-05 | 196 | 94 | 5 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-|Liver / Manually curated celltypes from each tissue | 5.98e-05 | 196 | 94 | 5 | 4ad73515af265432235b698fceb0ba370ced3e52 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.12e-05 | 197 | 94 | 5 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.12e-05 | 197 | 94 | 5 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.12e-05 | 197 | 94 | 5 | ccabb976b5d4800e87e550640454a893fdb3b1b6 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.12e-05 | 197 | 94 | 5 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.12e-05 | 197 | 94 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.12e-05 | 197 | 94 | 5 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.27e-05 | 198 | 94 | 5 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 6.27e-05 | 198 | 94 | 5 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 6.27e-05 | 198 | 94 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.27e-05 | 198 | 94 | 5 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.27e-05 | 198 | 94 | 5 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 199 | 94 | 5 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.42e-05 | 199 | 94 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 6.42e-05 | 199 | 94 | 5 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.42e-05 | 199 | 94 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 199 | 94 | 5 | 0d63da0afa93741c37609d879941de202d9ac86c | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 6.42e-05 | 199 | 94 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.42e-05 | 199 | 94 | 5 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.58e-05 | 200 | 94 | 5 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | 30dc7ffef2052ee8610cdca952ca12f240bcec50 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 6.58e-05 | 200 | 94 | 5 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 6.58e-05 | 200 | 94 | 5 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 137 | 94 | 4 | 587a369b148bb2600c06db39298feddfc99cb6ad | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-04 | 152 | 94 | 4 | cefc0ab592e99badf145fb95adf9906cb81be81c | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-04 | 152 | 94 | 4 | c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-04 | 152 | 94 | 4 | c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 154 | 94 | 4 | c663e9834be0b45389a862dc3c13a1f988a3e5ee | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 157 | 94 | 4 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 157 | 94 | 4 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 157 | 94 | 4 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 159 | 94 | 4 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.58e-04 | 159 | 94 | 4 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 49 | 57 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.36e-04 | 50 | 57 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | SECKEL SYNDROME 2 | 8.40e-06 | 2 | 86 | 2 | C1847572 | |
| Disease | Seckel syndrome 1 | 2.51e-05 | 3 | 86 | 2 | C4551474 | |
| Disease | Seckel syndrome | 3.54e-05 | 22 | 86 | 3 | C0265202 | |
| Disease | Malignant neoplasm of breast | MST1 ADAMTS19 KDM3A SETD2 MYH9 MYOD1 PRKAA1 MKI67 GRIK3 SP110 PRRC2A PLXNB1 | 6.50e-05 | 1074 | 86 | 12 | C0006142 |
| Disease | colon cancer (is_implicated_in) | 1.59e-04 | 36 | 86 | 3 | DOID:219 (is_implicated_in) | |
| Disease | Embryonal Rhabdomyosarcoma | 2.32e-04 | 8 | 86 | 2 | C0206656 | |
| Disease | JT interval | 8.06e-04 | 248 | 86 | 5 | EFO_0007885 | |
| Disease | QT interval | 9.58e-04 | 534 | 86 | 7 | EFO_0004682 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.38e-03 | 914 | 86 | 9 | EFO_0004532 | |
| Disease | Chronic myeloproliferative disorder | 1.39e-03 | 19 | 86 | 2 | C1292778 | |
| Disease | hemifacial microsomia | 1.39e-03 | 19 | 86 | 2 | MONDO_0015398 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.52e-03 | 286 | 86 | 5 | EFO_0004346, EFO_0006930 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 2.41e-03 | 25 | 86 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.57e-03 | 93 | 86 | 3 | C1535926 | |
| Disease | isthmus cingulate cortex volume measurement | 2.61e-03 | 26 | 86 | 2 | EFO_0010310 | |
| Disease | thrombocytopenia (is_implicated_in) | 2.81e-03 | 27 | 86 | 2 | DOID:1588 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCLARRSGDLDALDK | 51 | Q5TYW2 | |
| DDSRARKLSTDLKRC | 211 | Q96P47 | |
| RKRKCRDVVDLSESL | 206 | Q96QE3 | |
| SSERRKEKSRDAARC | 11 | Q99814 | |
| SCLLRKLEESKRARQ | 496 | Q8IYX3 | |
| DDARARKLSNDLKRC | 191 | Q9UPQ3 | |
| RCLARRSGDLDARDK | 51 | Q5CZ79 | |
| RKDALESCKERRDGR | 951 | Q6UB99 | |
| EEREKKLASCSRHRF | 826 | Q99708 | |
| KDREDKRSALSCVIS | 486 | Q9UIG0 | |
| AREVKREALECSLKF | 701 | Q9HD20 | |
| RCLARRSGDLDALDK | 51 | A0PJZ0 | |
| ANKKDLRDSSCRLEQ | 16 | Q8N4C9 | |
| SRLCEDKYKDLRRSA | 306 | Q8ND76 | |
| EEFSKRRDLRKDCIF | 366 | Q8IYB7 | |
| KSRICAQLARFSEEK | 926 | Q9NRL2 | |
| KLSLQESESKRRCRK | 1396 | Q9NRL2 | |
| KEDLERFLRSKASNC | 526 | Q8TE59 | |
| ERNIEKCRIFTRSDK | 101 | Q6WBX8 | |
| RCLARRSGDLDALDK | 51 | Q5SQ80 | |
| LKECTKRHTDSIDRR | 321 | A1A4S6 | |
| DFLKKDRSCVTRQLR | 996 | Q6WCQ1 | |
| RDSKRCRERDFLKKV | 211 | Q5TA45 | |
| DNCKLRRRKLSFESE | 886 | Q9NS40 | |
| ESASCRLETKERELR | 121 | Q9ULE4 | |
| EKESRALDKELARCR | 866 | Q9P219 | |
| LEKSRAIRQAKDECS | 286 | Q7Z406 | |
| NLESSVRDRCKKEFT | 1531 | O43157 | |
| RLSKVNEAFETLKRC | 121 | P15172 | |
| ADLILNRCSESTKRK | 371 | P14598 | |
| KSSACRRKREFIPDE | 56 | Q16649 | |
| RCRQSLEDSESLRIK | 421 | Q96CN5 | |
| LDRILKQKCFSEREA | 506 | Q9UK32 | |
| CAEAEELRARLTAKK | 896 | P35579 | |
| CETDLLSIRAEFRKK | 301 | O76027 | |
| RDKVTENKRCLRSAR | 3146 | P46013 | |
| CVKKIRTRSHRDSED | 3241 | P46013 | |
| KAKRSDELSFCRGAL | 781 | P16885 | |
| LREKLREGRDASCSL | 651 | Q3BBV0 | |
| VRDLKSDLCESRQKS | 2606 | O95613 | |
| KLGSEESCKLRRLRF | 141 | Q6XUX3 | |
| FRKLRDAVKEAETCA | 781 | P29375 | |
| KEKDRRAQSRSRECD | 536 | Q13427 | |
| KRVRLAKEQESRADC | 1516 | Q460N5 | |
| RCLARRSGDLDALDK | 51 | Q5VUR7 | |
| GCNSSDKRLKRIELR | 1121 | P46100 | |
| NKCLRKDAESRRREL | 2346 | Q13535 | |
| GERKRKLVCTRESDQ | 896 | Q9P2N4 | |
| CRECRLDSLRKDKEQ | 546 | Q9Y4C1 | |
| SDLEVRRSSKENCAK | 366 | A0AVK6 | |
| SSKRRFERDCKEADR | 136 | Q96RU3 | |
| ERKLLRERLRCKSFD | 411 | Q8N4A0 | |
| ELNRLKRTASEDSCK | 1576 | P15924 | |
| LKAKLERSRQSAREC | 26 | O60519 | |
| CTDDDRLKFNKILRE | 1861 | Q8WXX0 | |
| EESLLLKDCKCRSRL | 61 | Q8IZI9 | |
| RKSKRCLELQENSDL | 566 | Q6P9A2 | |
| AKARRCERGLKTLES | 191 | Q5T0F9 | |
| SLLSLRKDSQSCRDK | 2401 | Q5VT06 | |
| RKGTASRVLKDRELC | 201 | P29372 | |
| KDKAASESIRVNRRC | 3006 | Q99698 | |
| ARSKCRDKRADVGEF | 436 | O00458 | |
| DRNSLCKKEEDTRSA | 116 | Q12912 | |
| CDKKFARSDELSRHR | 431 | O14901 | |
| KDDRLNKDRCVRLAL | 61 | Q7Z4H3 | |
| EKCGKRVDRLDQRRS | 466 | P26927 | |
| KLRKTAEREQRSFCS | 846 | Q13003 | |
| EKRLGFRDETCDKLR | 436 | Q15835 | |
| KNCSGKERDRRTDDL | 351 | Q9HC62 | |
| KAQKEDDVACSRRLS | 56 | Q93075 | |
| KDSDLLDRRKQCFTV | 346 | Q9NSN8 | |
| ERRAACAEKLKRLDE | 481 | P48634 | |
| DCSLSIRDARKRDKG | 106 | Q9NYZ4 | |
| DALSCFLIKRRDKTR | 796 | Q9C0D5 | |
| VETRAQKARTECARK | 331 | Q9HB58 | |
| QKARTECARKSRSEE | 336 | Q9HB58 | |
| EESVREASLCKKLRS | 421 | Q8IUC4 | |
| LCREFRAKLTSDAEK | 501 | Q8N5C6 | |
| RLCESNRVDAKTKLE | 171 | Q9UHB9 | |
| ICKNGRLDEKESRRL | 116 | Q13131 | |
| RNEKFCLSRLTAEEK | 286 | Q6UXG3 | |
| NSKRKFERDCREAEK | 136 | Q15642 | |
| KCRDSKFDIRRSNRS | 276 | Q86YI8 | |
| CSFAEELSRILEKRK | 811 | Q9NTN9 | |
| RSLGCKRKRECLDES | 46 | A6NKU9 | |
| DLRRKAARLVAAKCT | 286 | Q8WWY3 | |
| RAREERLAACAAKLK | 516 | Q5JSZ5 | |
| EESVREASLCKKLRS | 336 | A8MT19 | |
| RESKRTSENEAIKRC | 516 | Q9BYW2 | |
| KLSDFSFSKRCLRDD | 151 | Q9BXA7 | |
| CLKSSDLEQLRKIRR | 141 | Q6PML9 | |
| RCLKAVRKERSKESD | 456 | Q9HD40 | |
| RLAKNRSRDGTKDSC | 331 | Q9NY57 | |
| DRSCRSLDVCLNKKA | 391 | Q9BXG8 | |
| FCLSNQRKLSKDRDR | 181 | Q7RTU7 | |
| EREQSRLTSCLKKRE | 6 | Q9Y275 | |
| LRLKRRKFTFECSDG | 1501 | O75093 | |
| RERKRKISCLSFALD | 111 | Q9Y247 |